The decision to offer extracorporeal membrane oxygenation (ECMO) is based on a risk/benefit assessment and the likelihood of a treatable underlying condition or the feasibility of destination therapy (durable mechanical support or thoracic organ transplantation) should heart-lung function fail to improve. Patients who present following suspected suicide attempts who fail medical therapy may pose a dilemma for clinicians. An assessment to determine if a patient has a high likelihood of psychiatric recovery such that bridging with ECMO or ultimately destination therapy could or should be offered is not always feasible in the setting of critical illness. This case series reviews our institution's experience with ECMO in the management of five patients who presented following suspected or confirmed suicide attempts. All five patients survived to hospital discharge. Two had subsequent psychiatric admissions, one following a repeat suicide attempt. A discussion of these cases demonstrates the effectiveness of ECMO in supporting this group of patients in the short-term. The self-limited natural history of many psychiatric episodes, poisonings and traumatic injuries makes the use of ECMO a potentially reasonable support strategy. However, careful consideration must be given to psychiatric history and follow-up given the substantial commitment of resources, potential for complications and for stranding patients on extracorporeal therapy without definitive destination therapy.
Introduction
Advances in extracorporeal membrane oxygenation (ECMO) have allowed clinicians to offer a subset of patients with otherwise lifeending illnesses a supportive therapy by sustaining gas exchange, hemodynamics, or both. Before patients are placed on ECMO, a determination is made about the short-and long-term intent for the patient's most likely outcome; ECMO may be offered as a bridge to recovery, to decision, or to destination with durable mechanical support or thoracic organ transplantation. As ECMO is resource intensive and not without complications, a risk/benefit assessment should be made as part of this evaluation that includes exploration of any preexisting comorbid illness that may limit future options.
A similar risk/benefit assessment is made for all potential solid organ transplant candidates prior to listing. Given the donor organ shortage, patients are screened for any medical, psychiatric or psychosocial factors that might limit the success of and thus may preclude transplantation. Substance abuse is not a contraindication to transplantation, and guidelines from the International Society for Heart and Lung Transplantation stipulate that patients with a history of substance abuse within 24-months demonstrate that they can comply with structured rehabilitation programs prior to listing [1] . The same cannot be said for active suicidality as transplantation is not recommended in patients with self-injurious behavior. However patients with acute hepatic failure due to intentional acetaminophen overdose are offered liver transplantation. No specific guidelines are available for liver transplantation after an overdose and decisions are made on a case-by-case basis.
ECMO has been used successfully to support patients following suicide attempts [2, 3] . Both veno-arterial (VA) and veno-venous (VV) ECMO have been employed for cardiotoxic ingestions [5] [6] [7] [8] [9] [10] [11] [12] [13] and poisonings complicated by respiratory failure [14] . ECMO has also been employed in trauma patients without suicide attempts who develop acute respiratory distress syndrome (ARDS) or thoracic organ contusion [15] [16] [17] [18] . A retrospective cohort analysis of 62 patients following drug intoxication (intentional and unintentional) compared the use of ECMO in 14 patients to conventional medical therapy in 48 patients and suggested a survival benefit in the ECMO group [4] . While the self-limited natural history of many psychiatric episodes, poisonings and trauma makes ECMO appealing for such patients, recovery cannot be guaranteed. Some consideration should be given to the availability of longer-term options a priori, but such an assessment is not always feasible in critically ill and acutely decompensated psychiatric patients.
In this case series we present our institution's experience with the use of ECMO in the management of five patients who presented following suspected or confirmed suicide attempts between 2013 and 2015. This study was approved by our Institutional Review Board (#419816). Case details were culled from the electronic medical record including evidence of prior and continued psychiatric care, emergency department (ED) visits, and hospitalizations. It is our hope that a review of these cases will provide a framework with which to explore the medical and psychiatric implications of using ECMO in this group of patients. Discussing possible ethical dilemmas posed by using such a resourceintensive support modality to manage patients who have decided to take their own life will provide insight into potential biases that might arise when considering the utility of such advanced therapies in patients with psychiatric disease.
Case 1
A 19-year-old male with a history of bipolar disorder and Asperger syndrome presented after being found unresponsive and cyanotic (Table 1) . He was in his usual state of health the night prior and his parents were unaware of a prior history of drug abuse or suicide attempts. The patient had pinpoint pupils and was given naloxone en-route without improvement. He was intubated on arrival and his chest x-ray revealed diffuse bilateral airspace disease concerning for massive aspiration. His urine drug screen was positive for benzodiazepine and methadone, neither of which he was prescribed. The patient developed refractory ARDS and was transferred to our institution for consideration of ECMO. On arrival to the medical intensive-care unit (ICU) the patient decompensated requiring vasopressor and inotropic support. He was supported on VA-ECMO for three days. His course was complicated by Staphylococcus aureus pneumonia.
Following extubation he admitted to overdosing on alprazolam and methadone because he was depressed, later stating his overdose was accidental. On psychiatric assessment there was no evidence of acute mood disturbance, psychosis, or active suicidality, and he was discharged to outpatient psychiatric follow-up and substance drug rehabilitation treatment. Since discharge the patient has had several ED visits for drug overdoses, two requiring inpatient admission.
Case 2
A 17-year-old male with a history of severe depression, anxiety, obsessive-compulsive disorder and associated suicidality without any prior suicide attempts presented following an unwitnessed overdose. He admitted to ingesting multiple medications including venlafaxine, escitalopram, amphetamine/dextroamphetamine, buspirone, fluoxetine, as well as his father's hydrochlorothiazide, atorvastatin and amlodipine. En-route to the hospital the patient had a witnessed seizure. An electrocardiogram revealed bradycardia and a widened QRS-interval. His condition quickly deteriorated progressing to cardiogenic shock refractory to atropine, glucagon and calcium, intralipid, a bicarbonate drip, and transcutaneous pacing. The patient was supported on VA-ECMO for three days. His course was complicated by rhabdomyolysis and myonecrosis of his left lower extremity which resolved with time and physical rehabilitation.
After medical clearance the patient was transferred for inpatient psychiatric treatment. Since discharge home he has been compliant with his outpatient psychiatric treatment program. He was readmitted to the inpatient psychiatric unit the following year after a repeat suicide attempt via wrist-cutting.
Case 3
A 36-year-old male with a history of bipolar disorder presented unresponsive and hypotensive following a presumed intentional jump from a second-story window. He had been hospitalized two months earlier for suicidality and was staying with his mother who reported non-adherence with his psychotropic medications. She reported he had just returned from visiting his estranged wife and that he was very anxious when she last saw him. She later found him unresponsive outside her home.
On arrival to the ED he was intubated. His trauma evaluation revealed seven left rib fractures, a left hemo-pneumothorax, a right pneumothorax, bilateral pulmonary contusions, multiple transverse process fractures of the spine, a left acetabular fracture and a right femoral neck fracture. Serum alcohol and urine drug screens were negative. His echocardiogram and computed tomography of the chest demonstrated a significant anterolateral cardiac contusion, a large pericardial effusion with tamponade and a left-ventricular ejection fraction of 10%. He was managed medically for two days and required a rightsided chest tube and a pericardial window and drain. He developed refractory respiratory failure and cardiogenic shock despite inotropic and vasopressor support and was placed on VA-ECMO. The patient remained on ECMO for 10 days and his course was complicated by bilateral lower extremity deep venous thromboses.
As part of his assessment for bridging to destination therapy a heart transplant center was contacted but transfer for transplant evaluation was declined. Discussions by the ICU team including possibly terminating ECMO given a lack of possible destination therapy and the risk of stranding him on ECMO was curbed after the patient's native cardiac function partially recovered allowing him to be decannulated. After decannulation the patient's course was further complicated by a left frontal ischemic stroke secondary to a left ventricular thrombus.
The patient was evaluated by psychiatry throughout his hospital stay who documented suboptimal cognition, no consistent recollection of events prior to admission (including whether he had fallen or jumped in a suicide attempt), and no active psychosis or suicidality. He was discharged to rehabilitation with ongoing psychiatric consultation. After discharge the patient had multiple ED visits and admissions for congestive heart failure exacerbations. He had no further documented psychiatric ED visits or admissions. Review of the electronic medical record 11 months after index presentation indicates the patient ultimately expired from congestive heart failure. His persistent encephalopathy made him a poor medical candidate for cardiac transplantation.
Case 4
A 44-year-old male with a history of bipolar disorder, polysubstance abuse, nonadherence, prior suicide attempts, and a recent ED evaluation for suicidal ideation while intoxicated presented following an intentional jump off a bridge from an approximate height of 66 m. His trauma evaluation revealed multiple injuries including bilateral rib fractures, bilateral pulmonary contusions and pneumothoraces, a T8-9 vertebral body burst fracture, a T9 transverse process fracture, T2 and T6-8 spinous process fractures, and a distal left radius fracture. He was intoxicated with a serum ethanol level of 80 mg/dL and his urine drug screen was positive for cocaine. He was intubated and bilateral chest tubes were placed.
On arrival the patient required aggressive resuscitation and bronchoscopy for collapse of the right lower lobe of the lung. He was placed on VV-ECMO for refractory hypoxemia due to ARDS and supported for 9 days. His course was complicated by an occlusive thrombus of the right internal jugular vein and methicillin-sensitive Staphylococcus aureus and Haemophilus influenza pneumonias.
The patient was evaluated by psychiatry throughout his hospital course. His delirium was treated with olanzapine, outpatient psychotropic agents with which he had been non-adherent were resumed, active substance abuse and withdrawal were addressed, and his depression and suicidality resolved. He was discharged and outpatient follow-up was eventually resumed in the community. Since discharge the patient has had several ED visits for medical complaints. He has had no subsequent documented psychiatric ED visits or admissions.
Case 5
A 41-year-old male with a history of bipolar disorder, anxiety, panic disorder, insomnia and alcohol abuse presented after being found on the side of the road next to his motorcycle with evidence of significant blood loss. The patient initially claimed he had been assaulted. His mother reported that he was having difficulty dealing with the recent loss of his brother and the patient later admitted to a possible suicide attempt.
On arrival the patient was hypotensive requiring aggressive fluid resuscitation. His trauma evaluation revealed multiple injuries including an open left-distal femoral fracture, a pelvic fracture, an extraperitoneal bladder rupture, and multiple complex right femoral lacerations. He was intoxicated with a serum alcohol level of 312 mg/dL and his urine drug screen was positive for marijuana. He was taken to the operating room for repair of his bladder, pelvis and femur, and admitted to the ICU. Seven days into his hospital stay he developed acute hypoxic respiratory failure secondary to fat emboli requiring reintubation. His course was further complicated by refractory ARDS and Haemophilus influenza pneumonia and he was placed on VV-ECMO for 35 days. His ECMO course was complicated by clotting of the oxygenator requiring 2 circuit replacements and bleeding at the cannulation site requiring transfusion.
The patient was evaluated by psychiatry after being extubated. There was no evidence of persistent exacerbated depression or psychosis. He denied active suicidality, was motivated for continued care, and was discharged to outpatient psychiatric follow-up. Since discharge the patient has had medical follow-up visits but no documented psychiatric ED visits or admissions.
Discussion
The successful use of ECMO in the treatment of adult poisoning and trauma patients has been previously described in case reports and small series [2, 3, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] 16, 19] . In our case series we successfully employed ECMO in five patients following suspected or confirmed suicide attempts. All five patients were discharged from the hospital, but some had prolonged courses with complications. One patient died approximately a year after ECMO support from heart failure.
The median age of the five patients was 36 years old, with a range of 17-44 years old. This is not surprising given the disproportionately higher risk of suicide in the young. The Centers for Disease Control and Prevention reported 42,773 suicide-deaths in the United States in 2014. Suicide is the tenth leading cause of death for all age groups, the second leading cause of death in people aged 10-34, and the fourth leading cause of death in people aged 35-54 [20] . Younger patients are likely to have fewer co-morbidities, which may make provision of ECMO (and stranding on ECMO) less risky. Excluding their psychiatric illnesses, three of our patients were otherwise healthy, one suffered from epilepsy and another had rheumatoid arthritis. A recent review of outcomes from the Extracorporeal Life Support Organization registry comparing in-hospital mortality between the elderly and the young revealed unsurprisingly that younger patients had a statistically lower mortality and a lower rate of multi-organ failure [21] .
The last available electronic medical record entries were reviewed for each patient 11-44 months after ECMO explantation. Four of the five patients were alive at this time. Follow-up of the five patients revealed that three had no documented subsequent ED visits or admissions for psychiatric complaints. One patient however had multiple subsequent ED visits and inpatient admissions for drug overdoses, and another was re-admitted seven months after discharge following a repeat suicide attempt. This patient's history was unremarkable for suicidality prior to the index admission. Post-ECMO he was psychiatrically hospitalized for 21 days and was discharged to well-documented psychiatric follow-up. These latter two cases raise a potential ethical dilemma when considering the use of ECMO to treat patients who have decided to take their own life and who have resistant or difficult to treat psychiatric illness or suicidality. Patients who attempt suicide have a significant rate of attempting suicide again [22] particularly in the year following the first attempt [23] [24] [25] . Up to 25% of patients seen in the ED following a suicide attempt will return after another attempt; 5-10% will eventually complete suicide [26] .
Life-saving medical therapy should not be withheld on the presumption of recurrence of suicidality for the same ethical reasons that treatments are not withheld from patients with acute or chronic and relapsing medical illnesses. This is especially important in the acute setting when managing critically-ill psychiatric patients who, without any other alternative therapy and after failing all conventional therapies, would likely die. In this acute setting suicidality is often presumed but not proven, making the decision to possibly withhold a potentially life-saving treatment particularly problematic. Suicidality, like many acute psychiatric episodes, even if recurrent, is often reversible. Additionally, many patients attempt suicide in the face of acute stressors, reversible adjustment disorders, and acute intoxication and in the absence of chronic depressive, bipolar, or psychotic disorders. These patients often make remarkable psychiatric recovery after acute medical and psychiatric care is provided for what is frequently a one-time event.
Continued psychiatric care and follow-up after medical recovery can be provided to decrease the risk of suicide. Identifying and addressing risk factors for suicide can also help partially mitigate this risk.
The concept of rational suicide, that is, a legitimate decision made by a competent individual that should be respected, is highly controversial. Regardless of one's personal belief system, in this circumstance honoring the autonomy of the patient's wish to die by suicide (thereby withholding ECMO) would first require deeming them fully capacitated. This is not feasible in the acute setting of critical illness and the principle of beneficent intent would require that the patient be treated with any/ all available life support measures. Many patients who commit suicide are not rational, but in fact are suffering from a treatable disease that has progressed to a degree of severity leading to suicidality, and thus are deserving of aggressive care, including ECMO, like any other patients with reversible illness.
Some precedent for the provision of scarce and complication-prone resources to high-risk psychiatric patients exists in solid organ transplantation, where suicidality is not always a contraindication. Patients undergo a thorough multidisciplinary evaluation to identify factors that might increase their risk of relapse including a history of nonadherence, substance abuse, prior self-harm and the absence of a support network. A retrospective study revealed comparable outcomes between patients transplanted following intentional acetaminopheninduced acute liver failure and those transplanted electively for chronic liver disease, in spite of a higher burden of psychiatric illness in the acetaminophen group. All the patients in the acetaminophen group were given long-term follow-up with psychiatry which likely contributed to their comparable outcomes to those with chronic liver disease [27] .
While it is appropriate to consider preexisting psychiatric illness as part of a risk/benefit assessment that may limit future options for destination therapy, it should not create an obstacle or the appearance of a potential ethical dilemma that might limit the use of life-saving treatments, including ECMO, in the acute setting of a suspected or confirmed suicide attempt [28] . The multidisciplinary evaluation patients undergo prior to being listed for transplantation is only necessary given the national shortage of donor organs. This does not apply to therapies including ECMO where patients are not competing with others awaiting the same therapy. As a matter of practical concern, use of resourceintensive and costly treatments in chronic psychiatric patients should be approached from the perspective of overarching diagnostic, prognostic, and quality-of life considerations and take into account both medical and psychiatric status. Also relevant is the fact that ECMO is not available in most US hospitals. Nevertheless, ECMO should be offered to these patients for the same reasons it is offered to those with acute or chronic and relapsing medical illnesses, including those exacerbated by nonadherence. The largest trial of VV-ECMO for respiratory failure to-date found ECMO to be cost-effective [29] and similar findings have been reported for VA-ECMO for patients in shock or cardiac arrest secondary to cardiac poisoning as compared to standard therapy [30] . Ideally, a cost-benefit analysis would also include the consideration of required long-term psychiatric follow-up care and substance abuse treatment, when applicable. As it is impossible to forecast this at presentation, ECMO should still be offered to these patients but only after standard medical therapy fails and with an eye towards futility if no potential durable support or transplant options exist.
Conclusion
ECMO can be an effective support modality for patients presenting following suicide attempts with refractory cardiopulmonary and respiratory failure. When indicated it should be offered to these patients when standard medical therapies fail, allowing them every opportunity of making a meaningful recovery. Ideally, it should be part of a multidisciplinary approach to care including long-term psychiatric follow-up.
